By Dave Andrusko
Among the many pro-life measures President Trump undertook during his four years in office was to end HHS funding for new medical research using human fetal tissue obtained from elective abortions, unless authorized by an ethics advisory board. Since pro-abortionists have falsely insisted for decades that this cramps medical research, we always anticipated that the new HHS Secretary—pro-abortion Xavier Becerra—would have something to say about that.
Today, testifying about his HHS Budget request for fiscal year 2022, Secretary Becerra told Rep. Mark Pocan (D-Wi.) that they will be making an announcement tomorrow on the “fetal tissue research ban.”
Since it will be distorted beyond measure tomorrow, it is very important to know what the “ban” actually does, not the relentless gloom and doom we’ll hear from proponents of unlimited use of your tax dollars to do research on tissue taken from aborted babies.
In June 2019, HHS announced that it would discontinue intramural research (i.e., internal) projects involving fetal tissue from elective abortions at the National Institutes of Health (NIH). It would also let expire an existing contract for human fetal tissue research with the University of California at San Francisco. Taxpayer money could no longer be used by NIH researchers to buy human fetal brains, livers, thymuses, or any other desired organ obtained from an elective abortion.
Pointing to all the research that continued, scholars at the Charlotte Lozier Institute noted,
Clearly research does not stop when ethical guidelines are put in place. Science continues to move forward without exploiting human fetal tissue from ongoing abortions.
Secretary Becerra’s heads up comes the same day as a devastating post appeared at The Federalist. The headline reads, “Federal Government Caught Buying ‘Fresh’ Flesh Of Aborted Babies Who Could Have Survived As Preemies.”
While the post is extremely difficult to read, it requires our full attention. Here are the opening three paragraphs of Edie Heipel’s story:
Last week, legal accountability group Judicial Watch dropped a bombshell: a nearly 600-page report proving the U.S. government has been buying and trafficking “fresh” aborted baby body parts. These body parts, purchased by the U.S. Food and Drug Administration to “humanize” mice and test biologic drugs in scientific experiments, came from babies up to 24-weeks-old gestation, just weeks from being born.
While Americans may be used to hearing pro-lifers beat the warning drum on abortion groups harvesting baby bodies and selling them for research, (who hasn’t heard of the lawsuit against David Daleiden, who exposed Planned Parenthood haggling over baby lungs and livers at dinner parties?) this time, the U.S. government was the one trafficking baby parts.
Some of the exchanges of emails are sickening, almost beyond words. Remember these include abortions performed on late-term babies. Consider this paragraph:
When an ABR employee reassured the FDA they were working with doctors who performed late-term abortions, he admitted some tissue was unusable from a procedure that injects a poison called digoxin into the baby, destroying its cells and tissues. Once the chemical has done its work, an intact, dead baby is delivered. This method makes fetal tissue specimens unusable in experiments.
Then what abortion technique is used on these babies?
The penultimate paragraph captures this “unchecked abuse and commodification of preborn children”:
Americans should be outraged their government participates in the wide-scale human trafficking operation that created a market for harvesting the organs of murdered infants. In no humane society could such a violation of the human body and dignity occur, in which babies’ eyes are “harvested immediately upon death,” organs marketed based on sex, and personhood attributed to mice but not children.